Research Article

Impact of Clinical Pharmacy Services on KAP and QOL in Cancer Patients: A Single-Center Experience

Table 3

Scores of all scales and items of the EORTC QLQ-C30 questions before and after study in two groups.

VariableControl group ()Intervention group () Between groups
Before studyAfter studyBefore study After study

Overall quality of life scales
 Global QOL54.23 ± 19.2052.78 ± 18.920.32152.16 ± 18.7559.09 ± 18.350.0000.9320.000
Function
 Physical functioning64.25 ± 19.3964.54 ± 18.440.92863.80 ± 19.8165.28 ± 17.520.5970.8890.789
 Role functioning49.77 ± 30.3252.32 ± 30.040.62547.40 ± 30.1151.94 ± 29.490.4100.6340.867
 Emotional functioning59.61 ± 17.2860.19 ± 16.680.34058.1 ± 17.6880.00 ± 17.500.0000.6040.000
 Cognitive functioning67.59 ± 17.8967.13 ± 18.120.15967.31 ± 17.6168.83 ± 15.380.1090.9240.045
 Social functioning35.88 ± 22.1436.57 ± 21.960.47135.28 ± 21.7936.36 ± 20.720.0960.8680.759
Symptom scales
 Fatigue46.63 ± 23.5945.86 ± 22.400.26047.95 ± 19.6939.73 ± 22.440.0010.7120.001
 Nausea and vomiting37.04 ± 22.5937.73 ± 22.550.26037.23 ± 22.4430.95 ± 19.050.0010.9580.000
 Pain31.25 ± 19.3731.22 ± 19.440.32130.95 ± 18.8723.38 ± 16.280.0000.9240.000
Single items
 Dyspnea28.70 ± 27.0127.31 ± 25.220.26026.84 ± 23.5926.41 ± 22.520.3210.6540.523
 Sleep disturbance54.63 ± 25.8351.85 ± 26.760.10955.41 ± 25.7125.54 ± 23.510.0000.8530.000
 Appetite loss55.09 ± 27.5056.48 ± 26.030.32156.28 ± 26.6453.68 ± 26.580.1090.7900.064
 Constipation34.70 ± 28.2135.18 ± 27.910.78437.66 ± 28.7929.00 ± 27.220.0000.5300.001
 Diarrhea29.17 ± 27.9427.78 ± 27.400.08330.30 ± 28.7119.91 ± 24.340.0130.8070.021
 Financial difficulties77.78 ± 25.6378.24 ± 25.120.32178.79 ± 25.3179.22 ± 24.210.5670.8090.977

Data presented as mean ± SD.
Within-group comparison (prestudy versus poststudy scores), paired Student’s -test.
#Between-groups comparison (control versus intervention group, before study), independent Student’s -test.
Between-groups comparison (control versus intervention group, after study), Analysis of Covariance.